INS and Insulin resistance: In this model, there are both moderate impairment in insulin secretion and insulin resistance, which is a characteristic feature of T2DM (Ali et al., 2020; Gorinstein et al., 2007; Singh & Singh, 2010; Zhou et al., 2009).